Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars
Recruiting · NCT06257355 · Registry updated 2026-04-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars | Corneal Injuries, Corneal Scar, Craniocerebral Trauma, Eye Injuries, Facial Injuries, corneal disorder, eye disorder, injury, nervous system disorder, nervous system injury | Recruiting | Phase 1 | 2026-04-07 | NCT06257355 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Claris Biotherapeutics, Inc. | 3 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Francis Price Jr, MD | Indianapolis | United States | 2 |
| Legacy Devers Eye Institute | Portland | United States | 4 |
| Loma Linda University Eye Institute | Loma Linda | United States | 5 |
| Midwest Cornea Associates, LLC | Carmel | United States | 2 |
| Minnesota Eye Consultants | Minnetonka | United States | 4 |
| Stuart A. Terry, MD PA | San Antonio | United States | 2 |
| Virginia Eye Consultants | Norfolk | United States | 4 |